Literature DB >> 24304254

Improving BP control through electronic communications: an economic evaluation.

Paul A Fishman1, Andrea J Cook, Melissa L Anderson, James D Ralston, Sheryl L Catz, David Carrell, James Carlson, Beverly B Green.   

Abstract

BACKGROUND: Web-based collaborative approaches to managing chronic illness show promise for both improving health outcomes and increasing the efficiency of the healthcare system.
OBJECTIVE: Analyze the cost-effectiveness of the Electronic Communications and Home Blood Pressure Monitoring to Improve Blood Pressure Control (e-BP) study, a randomized controlled trial that used a patient-shared electronic medical record, home blood pressure (BP) monitoring, and web-based pharmacist care to improve BP control (<140/90 mm Hg). STUDY
DESIGN: Incremental cost-effectiveness analysis conducted from a health plan perspective.
METHODS: Cost-effectiveness of home BP monitoring and web-based pharmacist care estimated for percent change in patients with controlled BP and cost per mm Hg in diastolic and systolic BP relative to usual care and home BP monitoring alone.
RESULTS: A 1% improvement in number of patients with controlled BP using home BP monitoring and web-based pharmacist care-the e-BP program-costs $16.65 (95% confidence interval: 15.37- 17.94) relative to home BP monitoring and web training alone. Each mm HG reduction in systolic and diastolic BP achieved through the e-BP program costs $65.29 (59.91-70.67) relativeto home BP monitoring and web tools only. Life expectancy was increased at an incremental cost of $1850 (1635-2064) and $2220 (1745-2694) per year of life saved for men and women, respectively.
CONCLUSIONS: Web-based collaborative care can be used to achieve BP control at a relatively low cost. Future research should examine the cost impact of potential long-term clinical improvements.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24304254      PMCID: PMC3938103     

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  25 in total

1.  Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic.

Authors:  J Jaime Caro; Karen Lee
Journal:  Curr Hypertens Rep       Date:  2002-12       Impact factor: 5.369

2.  Confidence intervals for cost-effectiveness ratios: a comparison of four methods.

Authors:  D Polsky; H A Glick; R Willke; K Schulman
Journal:  Health Econ       Date:  1997 May-Jun       Impact factor: 3.046

3.  Hypertension control as predictor of mortality in treated men and women, followed for up to 30 years.

Authors:  Larus S Gudmundsson; Magnus Johannsson; Gudmundur Thorgeirsson; Nikulas Sigfusson; Helgi Sigvaldason; Jacqueline C M Witteman
Journal:  Cardiovasc Drugs Ther       Date:  2005-05       Impact factor: 3.727

Review 4.  Home blood pressure measurement: a systematic review.

Authors:  Willem J Verberk; Abraham A Kroon; Alfons G H Kessels; Peter W de Leeuw
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

5.  Effects of physical activity on life expectancy with cardiovascular disease.

Authors:  Oscar H Franco; Chris de Laet; Anna Peeters; Jacqueline Jonker; Johan Mackenbach; Wilma Nusselder
Journal:  Arch Intern Med       Date:  2005-11-14

6.  Does prevention of cardiovascular diseases lead to decreased cost of illness? Twenty years of experience from Finland.

Authors:  U Kiiskinen; E Vartiainen; M Pekurinen; P Puska
Journal:  Prev Med       Date:  1997 Mar-Apr       Impact factor: 4.018

7.  Blood pressure in adulthood and life expectancy with cardiovascular disease in men and women: life course analysis.

Authors:  Oscar H Franco; Anna Peeters; Luc Bonneux; Chris de Laet
Journal:  Hypertension       Date:  2005-06-27       Impact factor: 10.190

8.  Long-term cost and life-expectancy consequences of hypertension.

Authors:  U Kiiskinen; E Vartiainen; P Puska; A Aromaa
Journal:  J Hypertens       Date:  1998-08       Impact factor: 4.844

9.  Home blood pressure monitoring. Effect on use of medical services and medical care costs.

Authors:  K Soghikian; S M Casper; B H Fireman; E M Hunkeler; L B Hurley; I S Tekawa; T M Vogt
Journal:  Med Care       Date:  1992-09       Impact factor: 2.983

Review 10.  The hypertension team: the role of the pharmacist, nurse, and teamwork in hypertension therapy.

Authors:  Barry L Carter; Hayden B Bosworth; Beverly B Green
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-11-28       Impact factor: 3.738

View more
  13 in total

Review 1.  Economics of Self-Measured Blood Pressure Monitoring: A Community Guide Systematic Review.

Authors:  Verughese Jacob; Sajal K Chattopadhyay; Krista K Proia; David P Hopkins; Jeffrey Reynolds; Anilkrishna B Thota; Christopher D Jones; Daniel T Lackland; Kimberly J Rask; Nicolaas P Pronk; John M Clymer; Ron Z Goetzel
Journal:  Am J Prev Med       Date:  2017-08-14       Impact factor: 5.043

Review 2.  Systematic Review of Self-Measured Blood Pressure Monitoring With Support: Intervention Effectiveness and Cost.

Authors:  Sharada S Shantharam; Mallika Mahalingam; Aysha Rasool; Jeffrey A Reynolds; Aunima R Bhuiya; Tyra D Satchell; John M Chapel; Nikki A Hawkins; Christopher D Jones; Verughese Jacob; David P Hopkins
Journal:  Am J Prev Med       Date:  2021-10-20       Impact factor: 5.043

3.  Cardiovascular Events and Costs With Home Blood Pressure Telemonitoring and Pharmacist Management for Uncontrolled Hypertension.

Authors:  Karen L Margolis; Steven P Dehmer; JoAnn Sperl-Hillen; Patrick J O'Connor; Stephen E Asche; Anna R Bergdall; Beverly B Green; Rachel A Nyboer; Pamala A Pawloski; Nicole K Trower; Michael V Maciosek
Journal:  Hypertension       Date:  2020-08-31       Impact factor: 10.190

Review 4.  Telemedicine and M-Health in Hypertension Management: Technologies, Applications and Clinical Evidence.

Authors:  Stefano Omboni; Marina Caserini; Claudio Coronetti
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-12

5.  Pharmacist-led hypertension management combined with blood pressure telemonitoring in a primary care setting may be cost-effective in high-risk patients.

Authors:  Stefano Omboni
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-20       Impact factor: 3.738

Review 6.  Physician-pharmacist collaborative practice and telehealth may transform hypertension management.

Authors:  Stefano Omboni; Mauro Tenti; Claudio Coronetti
Journal:  J Hum Hypertens       Date:  2018-12-13       Impact factor: 3.012

7.  Economic Evaluation of the Home Blood Pressure Telemonitoring and Pharmacist Case Management to Control Hypertension (Hyperlink) Trial.

Authors:  Steven P Dehmer; Michael V Maciosek; Nicole K Trower; Stephen E Asche; Anna R Bergdall; Rachel A Nyboer; Patrick J O'Connor; Pamela A Pawloski; JoAnn M Sperl-Hillen; Beverly B Green; Karen L Margolis
Journal:  J Am Coll Clin Pharm       Date:  2018-04-14

Review 8.  Pharmacist Interventions for Medication Adherence: Community Guide Economic Reviews for Cardiovascular Disease.

Authors:  Verughese Jacob; Jeffrey A Reynolds; Sajal K Chattopadhyay; David P Hopkins; Nicole L Therrien; Christopher D Jones; Jeffrey M Durthaler; Kimberly J Rask; Alison E Cuellar; John M Clymer; Thomas E Kottke
Journal:  Am J Prev Med       Date:  2021-12-04       Impact factor: 5.043

Review 9.  Intervention planning for a digital intervention for self-management of hypertension: a theory-, evidence- and person-based approach.

Authors:  Rebecca Band; Katherine Bradbury; Katherine Morton; Carl May; Susan Michie; Frances S Mair; Elizabeth Murray; Richard J McManus; Paul Little; Lucy Yardley
Journal:  Implement Sci       Date:  2017-02-23       Impact factor: 7.327

10.  Improving management and effectiveness of home blood pressure monitoring: a qualitative UK primary care study.

Authors:  Sabrina Grant; Sheila M Greenfield; Arie Nouwen; Richard J McManus
Journal:  Br J Gen Pract       Date:  2015-11       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.